NASDAQ:CPIX

Cumberland Pharmaceuticals Earning Date

USA |NASDAQ |USD

CPIX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.04 $-0.00 $0.02
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $9.19M $9.06M $9.25M

Cumberland Pharmaceuticals's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

CPIX Earnings Date & History Chart

CPIX Earnings & Revenue Forecast

CPIX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $0.06 $0.06 $0.06
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $0.09 $0.09 $0.09
Dec 2022 1 $0.14 $0.14 $0.14

CPIX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $0.06 $0.08 $0.08
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $0.09 $0.08 $0.08
Dec 2022 1 / 0 $0.14 $0.10 $0.10

CPIX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 1 $12.18M $12.18M $12.18M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $40.97M $40.97M $40.97M
Dec 2022 1 $44.85M $44.85M $44.85M

CPIX Earnings Date & Revenue History

CPIX Earnings History

|
Show More
Show More

CPIX Revenue History

|
Show More
Show More

Cumberland Pharmaceuticals Next Earnings Date & Report

CPIX Next Earnings Date & Report Preview: Sep 2021 (FQ)

CPIX's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 1 analysts, the average EPS estimation for Cumberland Pharmaceuticals's next quarterly earnings is $-0.04, with a low EPS estimation of $-0.04, and a high estimation of $-0.04.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 1 downward. The EPS 1 month trend is $-0.04, the last 2 month trend is $0.01, and the 3 month trend is $0.01.

Based on 1 analysts, the average revenue estimation is $9.19M, with a low revenue estimation of $9.19M, and a high estimation of $9.19M.

Cumberland Pharmaceuticals Previous Earnings Dates & Reports

CPIX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Cumberland Pharmaceuticals's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.

CPIX's earnings per share (EPS) was $-0.00, beating the consensus analysts forecast of $-0.07 by 98.43%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by -101.57%, and lower than the same period a year before (Jun 2020) by -101.38%.

Revenues were $9.06M, better than the forecast of $9.05M by 0.01%, down by -14.06% from the previous quarter , and down by -5.65% from the same period last year.

The company reported a net income of $1.23M.

Free cash flow for the quarter was $2.65M , compared to $1.67M last quarter and $2.61M a year before.

CPIX ended the quarter with $15.58M in total debt, a decrease of -7.43% compared to the previous quarter, and a decrease of -20.30% compared to the same quarter a year before.

CPIX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cumberland Pharmaceuticals's previous annual earnings date was Mar 9, 2021 for its fiscal year ended Dec 31, 2020.

CPIX's earnings per share (EPS) was $0.12, beating the consensus analysts forecast of $-0.03 by -500.00% , and lower than the previous year's EPS (Dec 2019) by -61.29%.

Revenues were $37.44M, better than the forecast of $36.96M by 1.30%, and down by -21.23% from previous year's revenue.

The company reported a net income of $-3.34M.

Cumberland Pharmaceuticals reported a free cash flow of $3.30M for its fiscal year, compared to $2.04M a year ago.

The company ended the fiscal year with $18.20M in total debt, a decrease of -6.26% compared to the previous year.